Report Library
View More
Datamonitor Healthcare Oncology Dis...
May 19, 2022
Datamonitor Healthcare Oncology Dis...
May 19, 2022
Datamonitor Healthcare Oncology Dis...
May 18, 2022
Datamonitor Healthcare Infectious D...
May 17, 2022
Datamonitor Healthcare CV&Met Disea...
May 13, 2022
Datamonitor Healthcare CNS Disease ...
May 6, 2022
Datamonitor Healthcare Infectious D...
May 5, 2022
Datamonitor Healthcare CV&Met: Chem...
May 5, 2022
Datamonitor Healthcare Infectious D...
April 29, 2022
Datamonitor Healthcare I&I Disease ...
April 22, 2022
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 5/19/22 | Zealand Pharma (ZEAL) | Zegalogue for Hyperinsulinemia/Hypoglycemia | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/18/22 | Enanta Pharmaceuticals (ENTA) | EDP-938 for Respiratory Syncytial Virus (RSV) Treatment | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/16/22 | Bristol Myers Squibb (BMY) | Opdivo for Bladder Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/13/22 | UCB (UCB) | Bimzelx for Psoriasis | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/12/22 | Bristol Myers Squibb (BMY) | Deucravacitinib for Psoriasis | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 03/19/22 | Subscribers Only | Subscribers Only | Regulatory - PDUFA for sNDA/sBLA |
| 03/31/22 | Subscribers Only | Subscribers Only | Trial Data - Top-Line Results |
| 05/12/22 | Subscribers Only | Subscribers Only | Trial Data - Other |
| 05/12/22 | Subscribers Only | Subscribers Only | Trial Data - Other |
| 05/12/22 | Subscribers Only | Subscribers Only | Trial Data - Top-Line Results |
